SCHEMBL21716703

SCHEMBL21716703

c1ccc(-n2c3ccccc3c3cc(-c4nc5ccccc5nc4-c4ccc5cc(-n6c7ccccc7c7cc8cc(-n9c%10ccccc%10c%10c%11ccccc%11ccc%109)ccc8cc76)ccc5c4)ccc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTGES O14684 1/20 0.36
PTGER4 P35408 1/20 0.34
HPGD P15428 1/20 0.32
F2 P00734 1/20 0.32
F10 P00742 1/20 0.32
PRSS1 P07477 1/20 0.32
NPY5R Q15761 1/20 0.31
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
HSP90AA1 P07900 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
PKM P14618 1/20 0.30
HTT P42858 1/20 0.30
GRK6 P43250 1/20 0.30
PIK3CD O00329 1/20 0.30
PIK3CA P42336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716856 0.95 L3MBTL1 (0.35) KDM4EATML3MBTL1PTGESPTGER4
SCHEMBL21717535 0.95 PTGES (0.34) KDM4EATML3MBTL1PTGESPTGER4
SCHEMBL21716730 0.94 L3MBTL1 (0.41) KDM4EATML3MBTL1PTGESPTGER4
SCHEMBL21716958 0.93 L3MBTL1 (0.42) KDM4EATML3MBTL1PTGER4HPGD
SCHEMBL21717026 0.92 LMNA (0.34) KDM4EL3MBTL1PTGESHPGDNPY5R
SCHEMBL21716700 0.92 KDM4E (0.32) KDM4EATML3MBTL1PTGESF2
SCHEMBL21717027 0.92 HPGD (0.34) KDM4EPTGESHPGDLMNAPOLB
SCHEMBL21716254 0.91 ADORA2A (0.35) KDM4EL3MBTL1PTGESHPGDNPY5R
SCHEMBL21716237 0.91 MAPK10 (0.36) KDM4EL3MBTL1PTGESHPGDF2
SCHEMBL21716692 0.91 KDM4E (0.33) KDM4EATML3MBTL1PTGESPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 KDM4E 1813/4885ATM 3428/4885L3MBTL1 1427/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 KDM4E 1813/4885ATM 3428/4885L3MBTL1 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.